Drug Addiction Statistics in the USA: 2026 Update

Drug addiction statistics in the USA tell a story that is both sobering and, for the first time in years, quietly hopeful. In 2023, roughly 48.5 million Americans aged 12 and older — that is about 1 in every 6 people — met the clinical criteria for a substance use disorder (SUD). And while the numbers are still staggering, 2024 and early 2025 brought something the public health community had not seen in a long time: a meaningful, measurable decline in overdose deaths.

That decline does not mean the crisis is over. It means the crisis is changing. Fentanyl has reshaped the drug landscape in ways that catch users, families, and treatment providers off guard. Polysubstance use is now the norm rather than the exception. Mental health disorders are tangled up with addiction at rates nobody fully anticipated. And tens of millions of Americans who need help are still not getting it.

This article brings together the most current data available as of 2026 — from the CDC, SAMHSA, NIDA, and the American Medical Association — to give you a complete, honest picture of where the United States stands. Whether you are a researcher, a parent, a policymaker, or someone personally touched by addiction, these numbers matter. They shape funding decisions, treatment access, and the everyday choices made by communities across the country.

Drug Addiction Statistics in the USA: The Scope of the Problem

How Many Americans Struggle With Substance Use Disorder?

The headline number is hard to absorb, but it is important to sit with it. In 2023, 48.5 million Americans aged 12 and older — about 1 in 6 — faced a substance use disorder. That breaks down in the following way:

• 27.2 million people had a drug use disorder
• 28.9 million had an alcohol use disorder
• 7.5 million were battling both simultaneously

These figures come from the National Survey on Drug Use and Health (NSDUH), the most comprehensive source of self-reported substance use data in the country. They do not capture every case — many people never report their use or are never formally diagnosed — which means the real numbers are likely higher.

In 2024, 21.2 million adults suffered from both a mental health disorder and a substance use disorder concurrently. The overlap between mental illness and addiction is not a coincidence. It reflects a shared biology, shared risk factors, and a treatment system that has historically struggled to address both at the same time.

The Economic Toll of Drug Addiction

These figures are not just a public health issue — they carry an enormous financial cost. Addiction costs the United States $700 billion every year when you factor in lost workplace productivity, healthcare spending, criminal justice costs, and social services. That number puts the scale of the crisis in context. For comparison, the entire federal education budget hovers around $200 billion.

Overdose Deaths in the USA: What the 2024–2026 Data Shows

A Historic Decline — With Important Caveats

For the first time in roughly two decades, the overdose death trend has reversed in a significant way. New provisional data from the CDC’s National Vital Statistics System shows a nearly 24% decline in drug overdose deaths in the United States for the 12 months ending in September 2024, compared to the previous year. Provisional data shows about 87,000 drug overdose deaths from October 2023 to September 2024, down from around 114,000 the previous year.

According to CDC director Allison Arwady: “It is unprecedented to see predicted overdose deaths drop by more than 27,000 over a single year. That’s more than 70 lives saved every day.”

The AMA’s 2025 report on the overdose epidemic provides additional confirmation. Overdose deaths declined from more than 110,000 in 2023 to about 75,000 in 2024, yet the epidemic remains widespread and increasingly complex, driven by mixing opioids with other substances and an unpredictable illicit drug supply.

To put the current moment in historical context: peak overdose deaths in the USA occurred in June 2023 at 111,466, and while the national numbers are roughly back to pre-COVID levels, they remain 4 times higher than at the start of the century.

Why Are Overdose Deaths Finally Falling?

This is the question everyone is asking. According to public health experts, improved data systems which allow for real-time tracking of substance use, the expansion of overdose prevention strategies such as programs to ensure access to naloxone, buprenorphine, and drug-checking tools all played a significant role in bringing down mortality rates.

OD deaths dropped in nearly all states by 20–30% from peak years. That is a remarkable achievement — but it is not guaranteed to continue, especially given proposed cuts to federal public health funding.

The Opioid Crisis: Current Statistics for 2025–2026

Opioid Use Disorder and Misuse Numbers

The opioid epidemic remains the engine driving most of America’s overdose deaths. Here is what the current data shows:

• In 2023, an estimated 5.7 million Americans (approximately 2.0% of the population) had an opioid use disorder (OUD).
• 8.9 million or 3.4% of Americans aged 12 and older misuse opioids at least once over a 12-month period. Usership has remained consistent from 2021 to 2023.
• 5.3 million, or 90% of opioid misusers, use prescription pain relievers. Hydrocodone is the most commonly misused prescription opioid, with 3.6 million misusers.
• 660,000 opioid misusers, or about 7.4%, abuse heroin.

Fentanyl: Still the Dominant Threat

Illicitly manufactured fentanyl remains the single biggest driver of overdose deaths. Opioid prescriptions have decreased 52% since 2012, falling from 260.5 million to 125.7 million in 2024 — yet illicitly manufactured fentanyl has more than filled that gap.

According to the AMA, “Illicitly manufactured fentanyl and polysubstance use continue to put patients at risk, while barriers to pain care and addiction treatment persist.”

The drug supply is also evolving in dangerous directions. In 2025, substances like nitazenes and methadone analogues are relatively rare in the U.S. supply, but they introduce new competition to replace fentanyl. This kind of substitution effect has historically made the drug supply more unpredictable, not less.

Taking opioids for a period longer than 3 months increases the risk of addiction 15 times. Most persons in acute pain need no more than 7 days’ worth of medication.

Alcohol Use Disorder Statistics in the USA

Alcohol does not get the media coverage that fentanyl does, but the numbers are comparably devastating.

• Though legal, alcohol kills nearly 178,000 Americans every year. 84.1% of people ages 18 or older report drinking alcohol at some point in their lifetime.
• In 2023, an estimated 28.9 million Americans aged 12 and older battled an alcohol use disorder (AUD), or 10.2% of this population.
• Over half of all American adults have a family history of problem drinking or alcohol addiction.
• Among the 29.8 million individuals with Alcohol Use Disorder, less than 8% receive treatment.

That last figure is worth pausing on. Nearly 30 million people have a diagnosable alcohol disorder, and fewer than 1 in 12 is receiving any kind of help. It represents one of the most dramatic treatment gaps in all of American healthcare.

Marijuana and Cannabis Use Disorder

Cannabis has undergone a cultural and legal transformation over the past decade, and the addiction statistics have shifted along with it.

• 44% of those who have used marijuana in the past month may have some degree of marijuana use disorder.
• 1 in 6 users who start using before age 18 become addicted to marijuana.
• In 2023, 39.5% of college students used marijuana, with past-30-day cannabis use increasing from 16.1% in 1988 to 26.1% in 2023 among that group.

The normalization of marijuana use, particularly as more states legalize recreational cannabis, has contributed to a declining perception of risk among young people. That is a pattern public health researchers are watching carefully, because lower perceived risk tends to precede higher use rates.

Stimulant Addiction: Methamphetamine and Cocaine

Methamphetamine

Methamphetamine use has surged over the past decade, in part because the illicit supply shifted from domestic production to high-purity, low-cost product manufactured by Mexican cartels. It is now frequently found alongside fentanyl in the drug supply, dramatically increasing overdose risk.

• Stimulant addictions, including to methamphetamine and cocaine, are a significant and growing concern in the U.S.

Cocaine

• About 1.3 million Americans aged 12 and older (0.4%) struggled with a cocaine use disorder in the past year.
• 298,000 people received inpatient treatment for cocaine use disorder, while 542,000 received outpatient treatment.

Teen and Adolescent Drug Use Statistics

Young people are a particularly vulnerable population. Brain development continues into the mid-twenties, and early exposure to substances dramatically increases the lifetime risk of addiction.

• Young adults aged 18–25 are hit hardest, with 24.4% affected by substance use disorders.
• E-cigarette use is on the rise: over 20% of high school students use e-cigarettes, according to CDC data.
• As more states legalize marijuana, teen usage has increased. Teens are also less likely to perceive marijuana as harmful, which is contributing to higher use rates.
• Notably, 856,000 adolescents were reported to have had both a major depressive episode and a substance use disorder in the past year.

The combination of mental illness and substance use in teenagers is not just a treatment challenge — it is a developmental one. Early intervention is critical, and the data suggests the system is not intervening early enough.

Mental Health and Substance Use Disorder: The Dual Diagnosis Problem

One of the most consistent findings in addiction research is the relationship between mental health disorders and substance use disorders. They are not parallel crises — they are deeply intertwined.

• 84.5 million or 32.8% of adults over the age of 18 have either a substance use disorder or any mental illness (AMI).
• In 2024, 21.2 million adults suffered from co-occurring mental health and substance use disorders.
• In 2023, 17.1% of people aged 12+ had a substance use disorder, and 22.8% had any mental illness, with many experiencing both.

This dual diagnosis reality means that treating addiction without addressing mental health — and vice versa — leaves patients only halfway helped. Integrated treatment models are now widely considered best practice, though access remains uneven.

Racial and Geographic Disparities in Drug Addiction

Substance use disorder does not affect all communities equally. The data on racial and geographic disparities is important because it shapes where resources should go and whose stories are being heard.

Racial Disparities

• Drug overdose death rates in 2023 were highest among American Indian and Alaska Native people at 65.0 deaths per 100,000, adults ages 35–54 at 57.3 per 100,000, Black people at 48.5 per 100,000, and males at 45.6 per 100,000.
• In 2023, white people were the only racial/ethnic population group that experienced a statistically significant decrease in drug overdose deaths. Other population groups had nonsignificant changes or increases.
• 94.8% of African Americans with substance use disorders do not receive treatment, despite rising marijuana use and significant mental health challenges in those communities.

Geographic Disparities

• Western and Northeastern states report higher substance use rates, while the South reports lower rates — though Southern states often have fewer treatment resources relative to their need.
• Rural communities face particular challenges, including fewer treatment providers, greater stigma, and limited access to medication-assisted treatment (MAT).

The Treatment Gap: Who Is Getting Help and Who Isn’t

This may be the most important — and most frustrating — section of the entire article.

• Over 93% of those with a substance use disorder do not access specialty care.
• In 2023, only 7.9% of people with a past-year alcohol use disorder received any alcohol treatment. In raw numbers, that means 2.3 million out of approximately 29 million people with AUD got help, while over 26 million did not.
• In 2020, only 6.3% of 5.1 million young adults with substance use disorders got help at a rehab facility.

Despite these gaps, recovery is happening at scale. 22 million of 30.5 million adults (73.1%) who have faced a substance use problem are in recovery. That is one of the more overlooked statistics in public health conversations about addiction. Recovery is not rare — it is the norm for people who get and stay connected to support.

Medication-Assisted Treatment (MAT)

Medication-assisted treatment using FDA-approved drugs like buprenorphine, methadone, and naltrexone is the gold standard for opioid use disorder. It reduces cravings, prevents relapse, and lowers the risk of fatal overdose.

• In 2023, 4.5 million people received treatment for alcohol use disorder, and 2.3 million received medication-assisted treatment for opioids.
• The AMA has been pushing to eliminate prior authorization barriers for medications for opioid use disorder (MOUD) and to strengthen enforcement of mental health parity laws.

For more information on evidence-based treatment options, the Substance Abuse and Mental Health Services Administration (SAMHSA) maintains a national helpline and treatment locator available 24/7 at 1-800-662-4357.

The Threat of Federal Funding Cuts to Addiction Programs

The data on declining overdose deaths comes with a major asterisk. The public health infrastructure that helped produce those declines is now under financial threat.

• SAMHSA has experienced major staffing reductions, including staff working on the 988 Suicide and Crisis Lifeline, and faces a potential $1.07 billion funding cut for FY 2026.
• These actions followed the administration’s clawback of billions of dollars in public health funding already deployed in states and communities across the country, including funding for suicide prevention.
• Reducing access to drug treatment is exactly the wrong direction. Polling in 2025 revealed that compassion and second chances are supported by wide segments of the population, yet political decisions are moving in the opposite direction.

According to the Trust for America’s Health (TFAH), the declines in alcohol and drug deaths directly reflect the value of investments in prevention, mental health, harm reduction, and crisis services. Cutting those investments now — at a moment when momentum is finally on the side of public health — risks reversing the progress that took years to achieve.

Key Drug Addiction Statistics at a Glance

Here is a quick-reference summary of the most important data points from this article:

What These Statistics Mean for 2026 and Beyond

The data paints a complex picture. The overdose death decline is real and significant — the biggest single-year drop ever recorded. Naloxone distribution, expanded access to buprenorphine, drug-checking programs, and years of sustained public health investment all contributed. That is worth acknowledging.

At the same time, the underlying rates of substance use disorder have not meaningfully dropped. Tens of millions of Americans are still living with untreated addiction. The illicit drug supply is still evolving and dangerous. Fentanyl contamination is spreading to new drug categories. And the treatment gap — where over 90% of people with SUD receive no specialty care — has barely moved in a generation.

The challenge heading into 2026 is holding onto the gains while addressing the structural problems: inadequate insurance coverage for treatment, persistent stigma, racial and geographic disparities in access, and a funding environment that is moving in the wrong direction at the worst possible time.

Conclusion

Drug addiction statistics in the USA for 2026 tell a story of a country at a genuine inflection point. After decades of rising overdose deaths, the nation has recorded an unprecedented 24% decline in overdoses, with roughly 87,000 deaths in the 12 months ending September 2024, down from more than 110,000 the year before. Yet 48.5 million Americans still live with a substance use disorder, fewer than 8% of those with alcohol use disorder receive treatment, opioid misuse affects nearly 9 million people, fentanyl remains the dominant driver of overdose deaths, and proposed federal funding cuts threaten to undo the public health progress that made these improvements possible.

Recovery is achievable — over 22 million Americans are living proof of that — but only if the systems, policies, and funding needed to connect people to care are protected and expanded rather than dismantled.